ofloxacin has been researched along with fluconazole in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (15.00) | 18.2507 |
| 2000's | 14 (35.00) | 29.6817 |
| 2010's | 19 (47.50) | 24.3611 |
| 2020's | 1 (2.50) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Abbasoglu, U; Aki-Sener, E; Ertan, T; Kaynak, F; Ozkan, S; Temiz-Arpaci, O; Yalcin, I; Yildiz, I | 1 |
| Aki-Sener, E; Kaynak, F; Ozkan, S; Temiz-Arpaci, O; Yalçin, I; Yildiz, I | 1 |
| Aki, E; Alper-Hayta, S; Arisoy, M; Kaynak, F; Ozkan, S; Temiz-Arpaci, O; Yildiz, I | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Aki, E; Bolelli, K; Ertan, T; Kaynak, F; Ozkan, S; Tekiner-Gulbas, B; Temiz-Arpaci, O; Yalcin, I; Yildiz, I | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Aytemir, MD; Ozçelik, B | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
| Chen, K; Ge, Z; Huang, Y; Ji, Q; Liao, F; Liu, X; Wu, H; Yang, X; Yuan, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Chen, S; He, S; Liu, X; Qiu, G; Shi, J; Tang, W; Wu, X; Xu, K; Zhang, J | 1 |
| Zhang, B | 1 |
| Balzarini, J; De Clercq, E; Karki, SS; Kulkarni, AA; Kumar, S; Veliyath, SK | 1 |
| Danisovicovà, A; Krcméry, V; Mardiak, J; Minárik, T; Sajben, P; Tomásik, E; Trupl, T | 1 |
| Demitrovicová, A; Grausova, S; Grey, E; Koren, P; Kralóvicová, K; Krcméry, V; Krupova, I; Kukucková, E; Kunová, A; Lacka, J; Oravcová, E; Pichna, P; Spanik, S; Svec, J; Trupl, J | 1 |
| Foltinova, A; Kaiserova, E; Kiskova, M; Kovacicova, G; Krchnakova, A; Krcmery, V; Krupova, I; Kunova, A; Trupl, J; West, D | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Bücheler, E; Bumann, D; Kramer, J; Maas, R; Steiner, P; Weber, C; Zander, AR | 1 |
| Bowersox, J | 1 |
| Kohno, S; Maesaki, S; Miyazaki, Y; Sasaki, E; Tashiro, T; Tomono, K; Yanagihara, K | 1 |
| Gehrs, KM; Heilskov, TW; Kherani, A; Kherani, F; Sutphin, JE; Wagoner, MD | 1 |
| Avorn, J; Fischer, MA; Solomon, DH; Teich, JM | 1 |
| Gandhi, PJ; Menezes, PA; Ramaswamy, K; Rivera, AL; Vu, HT | 1 |
| Biser, SA; Donnenfeld, ED; Doshi, SJ; Lee, CC; Perry, HD; Solomon, R | 1 |
| Bederson, JB; Eloy, JA; Smouha, EE | 1 |
| Bai, XQ; Deng, SJ; Li, R; Liang, QF; Luo, SY; Sun, XG; Wang, ZQ | 1 |
| Erasmus, J; Mattiuzzi, GN; Sever, M; Verstovsek, S | 1 |
| Andreeva, IV; Belikov, AN; Evstaf'ev, VV; Fokin, AA; Grinev, AV; Khrianin, AA; Kirpicheva, NN; Korolev, SV; Kozlov, SN; Serdiutskaia, MV; Stetsiuk, OU | 1 |
| Estes, LL; Wilson, JW; Zeuli, JD | 1 |
| Ansari, FL; Ashraf, Z; Baseer, M | 1 |
| Datau, EA | 1 |
| Caridha, D; Grogl, M; Harris, M; Hickman, M; Hudson, TH; Lang, T; Lecoeur, H; Leed, S; Ngundam, F; O'Neil, M; Parriot, S; Read, L; Sciotti, R; Sena, J | 1 |
| Akhir, A; Bhatta, RS; Bisen, AC; Chopra, S; Kedar, A; Krishna, A; Mugale, MN; Sanap, SN; Yadav, KS | 1 |
3 review(s) available for ofloxacin and fluconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature.
Topics: Abscess; Acyclovir; Amphotericin B; Aneurysm, Infected; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Aspergillus; Caspofungin; Ceftazidime; Clindamycin; Echinocandins; Fluconazole; Humans; Leukemia, Hairy Cell; Lipopeptides; Male; Middle Aged; Mouth; Ofloxacin; Pneumonia; Pulmonary Artery; Pulmonary Aspergillosis; Valacyclovir; Valine; Vancomycin | 2010 |
2 trial(s) available for ofloxacin and fluconazole
| Article | Year |
|---|---|
Fluconazol plus ofloxacin in prophylaxis of infections in patients with acute leukemia: a comparative study.
Topics: Adult; Bacterial Infections; Drug Costs; Drug Therapy, Combination; Female; Fluconazole; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Ofloxacin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Time Factors | 1993 |
Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Bacteremia; Child; Colistin; Fluconazole; Fungemia; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Ofloxacin; Penicillin V; Penicillins; Retrospective Studies; Risk Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
35 other study(ies) available for ofloxacin and fluconazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzamides; Microbial Sensitivity Tests; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2007 |
Synthesis and biological activity of some new benzoxazoles.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzoxazoles; Candida albicans; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2008 |
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
Topics: Amides; Anti-Bacterial Agents; Benzofurans; Benzoxazoles; Microbial Viability; Molecular Structure; Structure-Activity Relationship | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Benzoxazoles; Candida albicans; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
Topics: Animals; Anti-Infective Agents; Antiviral Agents; Bacteria; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Fungi; Herpesvirus 1, Human; Mannich Bases; Microbial Sensitivity Tests; Parainfluenza Virus 3, Human; Pyrones; Spectrum Analysis; Vero Cells | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Synthesis and biological evaluation of novel phosphoramidate derivatives of coumarin as chitin synthase inhibitors and antifungal agents.
Topics: Amides; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Chitin Synthase; Coumarins; Cryptococcus neoformans; Dose-Response Relationship, Drug; Enzyme Inhibitors; Microbial Sensitivity Tests; Phosphoric Acids; Structure-Activity Relationship | 2016 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Bacillus cereus; Dose-Response Relationship, Drug; Free Radicals; Hydrogen Bonding; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Synthesis and biological evaluation of 2-(5-substituted-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-
Topics: | 2013 |
Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteremia; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Fungemia; Humans; Neoplasms; Ofloxacin | 1997 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
[Importance of digital thoracic radiography in the diagnosis of pulmonary infiltrates in patients with bone marrow transplantation during aplasia].
Topics: Adult; Anemia, Aplastic; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Bone Marrow Transplantation; Diagnosis, Differential; Female; Fluconazole; Humans; Lung Diseases; Lung Diseases, Fungal; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies; Radiographic Image Enhancement; Radiography, Thoracic; Retrospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans.
Topics: Anti-Infective Agents; Antiviral Agents; Candida albicans; Drug Synergism; Fluconazole; Ofloxacin | 2000 |
Xanthomonas maltophilia endophthalmitis following penetrating corneal injury.
Topics: Amphotericin B; Cornea; Corneal Injuries; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Fluconazole; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Ofloxacin; Stenotrophomonas maltophilia; Visual Acuity | 2002 |
Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients.
Topics: Administration, Oral; Amiodarone; Drug Therapy, Computer-Assisted; Fluconazole; Humans; Infusions, Intravenous; Levofloxacin; Medication Systems, Hospital; Metronidazole; Ofloxacin; Practice Patterns, Physicians'; Ranitidine; Reminder Systems | 2003 |
Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient.
Topics: Anti-Infective Agents; Antifungal Agents; Fluconazole; Humans; Intensive Care Units; Levofloxacin; Male; Middle Aged; Monitoring, Physiologic; Ofloxacin; Torsades de Pointes; United States | 2003 |
Candida parapsilosis keratitis following treatment of epithelial ingrowth after laser in situ keratomileusis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Debridement; Drug Therapy, Combination; Epithelium, Corneal; Eye Infections, Fungal; Female; Fluconazole; Humans; Keratitis; Keratomileusis, Laser In Situ; Middle Aged; Ofloxacin; Postoperative Complications; Retrospective Studies; Surgical Flaps | 2004 |
Petrous apex aspergillosis as a long-term complication of cholesterol granuloma.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Basilar Artery; Cerebrospinal Fluid Rhinorrhea; Cholesterol; Fatal Outcome; Fluconazole; Granuloma, Foreign-Body; Headache; Humans; Magnetic Resonance Imaging; Male; Methicillin Resistance; Middle Aged; Neuroaspergillosis; Ofloxacin; Otorhinolaryngologic Surgical Procedures; Petrous Bone; Sphenoid Sinus; Subarachnoid Space | 2007 |
[Etiological analysis of ocular non-viral microbial isolates in children and their antibiotics susceptibility in vitro].
Topics: Adolescent; Anti-Infective Agents; Bacteria; Child; Child, Preschool; Drug Resistance, Microbial; Eye Infections; Female; Fluconazole; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Microbial Sensitivity Tests; Mitosporic Fungi; Ofloxacin; Retrospective Studies; Rifampin | 2009 |
[Diagnostic and treatment patterns in management of male patients with nongonococcal urethritis: results of Russian multicentral cross-sectional study].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Ceftriaxone; Chlamydia trachomatis; Cross-Sectional Studies; Doxycycline; Fluconazole; Guideline Adherence; Humans; Josamycin; Male; Metronidazole; Middle Aged; Mycoplasma genitalium; Mycoplasma hominis; Ofloxacin; Polymerase Chain Reaction; Practice Guidelines as Topic; Retrospective Studies; Russia; Trichomonas vaginalis; Ureaplasma urealyticum; Urethra; Urethritis | 2012 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Synthesis, in vitro antibacterial and antifungal activity of some n-acetylated and non-acetylated pyrazolines.
Topics: Acetic Acid; Acetylation; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Chalcones; Fluconazole; Hydrazines; Levofloxacin; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Structure; Ofloxacin; Pyrazoles; Spectroscopy, Fourier Transform Infrared | 2013 |
A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
Topics: Ambroxol; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Bronchodilator Agents; Budesonide; Candida albicans; Candidiasis; Ethanolamines; Expectorants; Fluconazole; Formoterol Fumarate; Glucocorticoids; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung Diseases, Fungal; Male; Methylprednisolone; Middle Aged; Ofloxacin | 2012 |
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Female; Firefly Luciferin; Fluconazole; Genes, Reporter; High-Throughput Screening Assays; Leishmania major; Leishmaniasis, Cutaneous; Luciferases; Luminescent Measurements; Macrophages; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Ofloxacin; Optical Imaging; Organisms, Genetically Modified; Organometallic Compounds; Triazoles | 2017 |
Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis.
Topics: Chitosan; Drug Compounding; Drug Delivery Systems; Fluconazole; Humans; Keratitis; Ofloxacin | 2022 |